Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

GreenMobility – Guidance Upgrade and Preliminary Results

By HC Andersen Capital
GreenMobility

You can already now sign up for the event and send in your questions. You don’t have to participate live to submit questions for the event.

On Tuesday July 8th 2025 GreenMobility released its preliminary figures and raised the lower end of its 2025 guidance. On Wednesday July 9th at 14:00, we are hosting an event with CEO Kasper Gjedsted, who will walk us through the preliminary results, the updated guidance, and what is driving the stronger-than-expected momentum. The session will conclude with a Q&A.

Preliminary Q2 2025 revenue showed a 24% increase, resulting in a 29% revenue growth for the first half of 2025. Margins improved, and EBITDA for H1 grew by 76% to DKK 24 million.

GreenMobility has raised the lower end of its full-year revenue guidance from 7–13% to 10–13%. In addition, the lower end of the EBITDA growth guidance has been raised from 20–40% to 25–40% compared to FY2024

Disclaimer: HC Andersen Capital receives payment for a Digital IR/Corporate Visibility subscription agreement. CEO of HC Andersen Capital, Tue Østergaard, owns shares and is the Chairman of the Board of GreenMobility. /Michael Friis at 09.31 AM, July 8th 2025.

 

Recent videos

A sit-down with CEO Remco Westermann
12.12.2025 klo 10.09 Verve Group
Aiforia as an Investment | Life Science Night Dec 9, 2025
11.12.2025 klo 12.00 Aiforia Technologies
Endomines as an Investment | Investor Day Nov. 24, 2025
10.12.2025 klo 13.30 Endomines Finland
Clas Ohlson, Audiocast, Q2'25
10.12.2025 klo 10.00 Clas Ohlson
Herantis Pharma as an Investment | Life Science Night Dec 9, 2025
09.12.2025 klo 23.11 Herantis Pharma
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.